Curing Influenza: Intense R&D for Vaccine Development
RNCOS latest research report titled “Global Vaccine Market Outlook 2020”, estimates that the global vaccine market will grow at a healthy CAGR of around 12% during 2013-2020. It has been observed that majority of vaccines in Phase III clinical trials are for influenza treatment. Sanofi leads the global market for influenza vaccine. It generated revenue of over US$ 1 Billion in 2013 from sales of influenza preventing vaccines, Fluzone and Vaxigrip. The major companies working on influenza include Sanofi, Novartis,...
View full press release